Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Benefits"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
dewey-ones:"330 - Economics"
language:"English"
Showing
101
-
120
of
231
Search:
'"Benefits"'
,
query time: 0.06s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
101
CADTH Canadian Drug Expert Committee recommendation: Isavuconazole (Cresemba -- Avir Pharma Inc.) : indication : for use in adults for the treatment of invasive aspergillosis, inva...
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
102
Pharmacoeconomic review report: Edaravone (Radicava) (Mitsubishi Tanabe Pharma Corporation) : indication : for the treatment of Amyotrophic Lateral Sclerosis (ALS)
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
103
Fluoroquinolones for the treatment of otitis media : a review of clinical effectiveness, cost-effectiveness, and guidelines
by
Jahagirdar, Deepa
,
Loshak, Hannah
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
104
Atypical injectable antipsychotics for schizophrenia or bipolar disorder : a review of clinical effectiveness and cost-effectiveness
by
Narain, Tasha
,
Ford, Caitlyn
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
105
Hydrogel spacers for patients with prostate cancer : a review of clinical effectiveness and cost-effectiveness
by
Chao, Yi-Sheng
,
MacDougall, Danielle
,
De Nanassy, Alina
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
106
Intravenous acetaminophen for the management of short-term post-operative pain : a review of clinical effectiveness and cost-effectiveness
by
Harricharan, Sharada
,
Frey, Nina
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
107
Pharmacoeconomic review report: Tiotropium bromide monohydrate and olodaterol hydrochloride (Inspiolto respimat) for oral inhalation
Published 2015
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
108
Bobath therapy for patients with neurological conditions : a review of clinical effectiveness, cost-effectiveness, and guidelines
by
Gray, Casey
,
Ford, Caitlyn
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
109
Carbon ion beam therapy for chordoma : a review of clinical effectiveness, cost-effectiveness, and guidelines
by
Williams, D.
,
Ford, Caitlyn
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
110
CADTH Canadian Drug Expert Committee recommendation: Cladribine (Mavenclad -- EMD Serono) : indication: relapsing-remitting multiple sclerosis
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
111
CADTH Canadian Drug Expert Committee recommendation: Levodopa/carbidopa intestinal gel (Duodopa -- Abbvie Corporation) : indication : Parkinson's disease
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
112
Pharmacoeconomic review report: Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi) (Gilead Sciences Canada, Inc.)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
113
CADTH Canadian Drug Expert Committee recommendation: Ivabradine hydrochloride (Lancora -- Servier Canada Inc.) : indication: heart failure, NYHA class II to III.
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
114
CADTH Canadian Drug Expert Committee final recommendation: Sapropterin -- resubmission (Kuvan -- BioMarin Pharmaceuticals Canada Inc.) : indication: to reduce blood phenylalanine l...
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
115
Folate testing : a review of the diagnostic accuracy, clinical utility, cost-effectiveness, and guidelines
Published 2015
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
116
CADTH Canadian Drug Expert Committee final recommendation: Selexipag (Uptravi -- Actelion Pharmaceuticals Canada Inc.) : Indication: pulmonary arterial hypertension
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
117
Pharmacoeconomic review report: Levodopa/Carbidopa (Duodopa) (Abbvie Corporation) : indication : for the treatment of patients with advanced levodopa-responsive Parkinson's disease
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
118
Pharmacoeconomic review report: Risankizumab (Skyrizi) (AbbVie)
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
119
Pharmacoeconomic review report: Teduglutide (Revestive) (Shire Pharmaceuticals Ireland Limited) : indication: treatment of adults and pediatric patients one year of age and above w...
Published 2020
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
120
Pharmacoeconomic review report: Onabotulinumtoxin A (Botox) (Allergan inc.) : indication: for the prophylaxis of headaches in adults with chronic migraine (plus/minus 15 days per m...
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
1
2
3
4
5
6
7
8
9
10
11
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Clear Filter
Classification: 330 - Economics
Clear Filter
Language: English
Year of Publication
From:
To:
Classification
330 - Economics
610 - Medicine & health
76
140 - Specific philosophical schools
19
700 - The arts; fine & decorative arts
17
580 - Plants (Botany)
3
600 - Technology
2
more ...
615 - Pharmacology & therapeutics
2
100 - Philosophy & psychology
1
363 - Other social problems & services
1
800 - Literature & rhetoric
1
see all ...
less ...
Language
English
Collection
National Center for Biotechnology Information
231
Author
Canadian Agency for Drugs and Technologies in Health
CADTH Canadian Drug Expert Committee
50
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
27
Adcock, Lorna
7
Ho, Chuong
7
Ford, Caitlyn
6
more ...
Grobelna, Aleksandra
5
Argáez, Charlene
4
Chao, Yi-Sheng
4
Gray, Casey
4
McCormack, Suzanne
4
Tran, Khai
4
Banerjee, Srabani
3
Campbell, Kaitryn
3
Loshak, Hannah
3
MacDougall, Danielle
3
Wells, Charlotte
3
Williams, D.
3
Young, Calvin
3
Farrah, Kelly
2
Frey, Nina
2
Jahagirdar, Deepa
2
Kanga, Ismat
2
Poitras, Veronica
2
Visintini, Sarah
2
Adams, Alison
1
Chiu, Stephanie
1
Cowling, Tara
1
De Nanassy, Alina
1
Edge, Rob
1
Harricharan, Sharada
1
Khangura, Sara
1
Klarenbach, Scott
1
Krahn, Murray
1
La Fleur, Philip
1
Lachance, Chantelle
1
Lee, Karen M.
1
Marchand, Dave K.
1
Membe, Stephen K.
1
Narain, Tasha
1
Palylyk-Colwell, Eugenia
1
Picheca, Lory
1
Singh, Sumeet
1
Spry, Carolyn
1
Thompson, Wade
1
Wong, William
1
Wright, Mary-Doug
1
Yeung, Shirley S. T.
1
see all ...
less ...
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?page=6&filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&filter%5B%5D=dewey-ones%3A%22330+-+Economics%22&filter%5B%5D=language%3A%22English%22&lookfor=%22Benefits%22&type=Subject
Send by Email
×
Loading...